AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
TP

Terns Pharmaceuticals

Executive

Terns Pharmaceuticals is a US-based biotechnology company focused on developing treatments for rare blood and bone marrow cancers.

Related Stories

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters

March 25, 2026